Every Drug Analog. Every source. In minutes.

The Drug Analog Digital Knowledge Worker automates the analog research, competitive intelligence and benchmarking work, across every public and licensed drug data source, with every fact cited to source.

Play Video
Play Video

Live in Production with Syneos Health

Screenshot 2026-06-19 at 20.18.09

Drug analog research faces 3 predictable issues:

The analog search takes weeks

A senior consultant opens more than ten tabs: OpenFDA, the Orange Book, the Purple Book, ChEMBL, ClinicalTrials.gov, RxClass, drug labels, licensed sources — and stitches the picture together by hand. Days per query. Often a full week for a defensible longlist. Project capacity is capped by analyst time.

Inconsistencies between analysts

There is no standard methodology, no shared benchmark for accuracy, no reproducibility test. When a client challenges the analog set or the conclusions drawn from it, there is no audit trail to defend the work.

Budget-constrained coverage

Time on discovery is limited by the project budget. In practice this means only a subset of sources and candidate analogs is fully explored and validated. Valuable information is systematically missed in the final data - not because the team isn’t capable, but because exhaustive search is too expensive to do by hand.

What does this Digital Worker do:

Executes in Minutes

The data work that took a senior consultant a week now takes minutes, freeing the team for judgment, not data gathering.

Surfaces Conflicts

When sources disagree, the Worker flags the conflict explicitly and shows you the underlying evidence. The consultant decides with full context. Nothing is silently reconciled.

Increases Coverage

Because time is no longer the constraint, the Worker explores a wider range of data sources & analogs than a project budget would normally allow - finding better matches, and lifting the quality of every downstream forecast and positioning decision.

Ask in plain English. Get a fully cited analog cohort in minutes.

Screenshot 2026-05-22 at 15.05.52
  • The Drug Analog Digital Knowledge Worker is built for commercial consultants and analysts, not engineers.
  • It takes a question in natural language, plans how to answer it, queries every relevant source in parallel, and returns a sortable, downloadable analog cohort with every fact referenced back to its source.

Every public source, every licensed source, in one workflow

Illustrative Coverage:

  • OpenFDA API and FDA drug labels
  • Orange Book and Purple Book
  • ChEMBL
  • ClinicalTrials.gov
  • RxClass
  • Citeline
  • Cortellis
  • OpenPayments
  • Orphanet
  • Drugs.com
  • Your internal repositories and licensed feeds
analog_identification_workflow

Built for the commercial teams that rely on analog intelligence

Building patient-funnel models and pre-launch forecasts that depend on analog benchmarking.

mapping the analog and biosimilar landscape for a brand or pipeline asset.

Benchmarking pricing, label and reimbursement positioning against comparable approved products.

Shaping winning label, indication sequencing and go-to-market strategy.

Delivering analog research at scale to biopharma clients, without growing headcount linearly with project volume.

Built on the four core capabilities of the causaLens Digital Worker platform

The Drug Analog Digital Knowledge Worker is a multi-agent system, governed end-to-end by the four core capabilities that underpin every causaLens Digital Worker. These are what make the difference between a chat interface and a production-grade automation.

The Multi-Agent Workflow:

A dynamic query layer over public, licensed and proprietary drug data sources. The Worker writes the schema needed to answer a question, then chooses, tests and validates the right sources on the fly. There is no expensive upfront mastering operation - the data mesh maps the relationships between sources as you use the system and remembers them for next time. For analog research, this means the Worker can incorporate a new licensed feed or an internal source within days, not quarters.

Integrations:

  • Drug and clinical data sources
  • Internal commercial data repositories and document stores, integrated via the Agentic Data Mesh
  • Your approved large language model - we are model-agnostic and bring-your-own-LLM
  • Deployment on causaLens cloud, your private cloud, or fully on-premise

What It Replaces & Reduces:

  • Multi-day analyst research cycles across more than ten sources
  • Manual reconciliation of conflicting source data
  • Ad-hoc, non-reproducible analog methodologies that vary between analysts
  • Lack of audit trail when clients or regulators challenge an analog set

Common questions, answered

Out of the box: OpenFDA and FDA drug labels, Orange Book, Purple Book, ChEMBL, ClinicalTrials.gov, RxClass, Citeline, Cortellis, OpenPayments, Orphanet and Drugs.com. We add internal repositories and additional licensed sources as part of a deployment.

Generic LLMs are not built for regulated commercial workflows. The Drug Analog Digital Knowledge Worker cites every fact to source, surfaces source conflicts explicitly rather than hiding them, applies configurable guardrails consistently across every query, and is benchmarked continuously for accuracy and reproducibility. It is governed, auditable and production-ready — not a chat interface.

Yes. We deploy on causaLens cloud, your private cloud, or fully on-premise. The Worker is model-agnostic — use our default model, or bring your own approved LLM. Your data never leaves your environment unless you choose otherwise.

Accuracy and reproducibility are measured continuously against curated reference queries built with your team. The benchmark suite runs against every release. We share the benchmark methodology and results during deployment.

Typical timeline: an MVP in two to three weeks against a small set of priority questions, followed by a production deployment scoped to your data, security and integration requirements. A dedicated causaLens AI engineer builds and runs the Worker; a causaLens value engineer owns project success.

Commercial consultants, forecasting analysts, competitive intelligence leads, market access strategists and launch teams. No engineering or data science background required. The interface is built for the questions consultants actually ask.

Production-grade, not prototype

Versus manual consulting effort

Days become minutes. The methodology is benchmarked and reproducible - it doesn’t vary by analyst, by week, or by client engagement. Project budgets no longer cap coverage. Senior consultants spend their time on judgment, not data gathering.

Versus generic LLM tools

Every value links back to its source. Conflicts between sources are surfaced explicitly. Accuracy and reproducibility are measured continuously against curated reference queries. Guardrails are configurable and consistently applied. Built for the regulated workflows your compliance and IT teams will scrutinise.

Versus data vendors

Specialist vendors give you the data. We give you the synthesis - governed, explainable, and reusable across every commercial use case your team owns.

The Reliability Framework

The capability that separates causaLens Digital Workers from copilots and other enterprise AI solutions. In-loop judges, hard-stop guardrails, provenance tracking and benchmark-first development. This is the layer that turns a long-running agent into a production-grade automation - trusted by commercial leaders, defensible to compliance teams, and auditable for regulators.